THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Will stars align again for biotech backer?

Constellation will tap DNA research to create drugs

By Todd Wallack
Globe Staff / April 29, 2008

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Millennium Pharmaceuticals Inc. cofounder Mark Levin has long been a key figure in the region's biotech industry. Known for his colorful shirts and even bolder statements, Levin, 57, once predicted Millennium would become a $100 billion company and revolutionize the way drugs work by unraveling the body's genetic code. Though the Cambridge biotech has yet to fulfill that promise, Levin ... (Full article: 1060 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass